Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.13
+0.17 (1.52%)
Nov 21, 2024, 12:09 PM EST - Market open
Artiva Biotherapeutics Employees
Artiva Biotherapeutics had 43 employees as of December 31, 2021. The number of employees increased by 21 or 95.45% compared to the previous year.
Employees
43
Change (1Y)
21
Growth (1Y)
95.45%
Revenue / Employee
$60,488
Profits / Employee
-$1,425,023
Market Cap
270.22M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 43 | 21 | 95.45% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zynex | 1,100 |
| AngioDynamics | 748 |
| Anika Therapeutics | 357 |
| Poseida Therapeutics | 330 |
| Fate Therapeutics | 181 |
| Atai Life Sciences | 83 |
| Atea Pharmaceuticals | 75 |
| Ocugen | 65 |
ARTV News
- 8 days ago - Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 9 days ago - Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch - Benzinga
- 4 months ago - Artiva: Natural Killer Cell Biotech With 1st Half Of 2025 Lupus Treatment Data - Seeking Alpha
- 4 months ago - U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week - Seeking Alpha